A nurse has received a report about a patient in labor.
The patient's last vaginal examination was recorded as 3 cm, 30%, and -2. What is the nurse's interpretation of this assessment?

Choice A rationale

Rupture of the amniotic membranes is a natural part of labor progression and a common procedure for labor induction or augmentation. While it is an important event to note and monitor for potential complications like cord prolapse, it is not a direct contraindication for oxytocin administration unless other signs of fetal or maternal compromise are present.

Choice B rationale

A fetal heart rate of 140 beats per minute with accelerations is considered a normal, reassuring finding. The normal fetal heart rate range is 110-160 beats per minute. Accelerations indicate a healthy fetal response to stimulation and adequate oxygenation. Therefore, this finding would support the continuation of oxytocin, not its discontinuation.

Choice C rationale

Uterine hyperstimulation, defined as more than five contractions in 10 minutes, is a significant complication of oxytocin augmentation. This can lead to fetal distress due to reduced uteroplacental blood flow during contractions. The prolonged and frequent contractions can compromise oxygen delivery to the fetus, necessitating immediate discontinuation of the oxytocin infusion to prevent adverse outcomes.

Choice D rationale

A patient needing to void is a normal physiological need. While the nurse should ensure the patient voids regularly to prevent bladder distention, which can impede fetal descent, it is not an indication to discontinue the oxytocin infusion. This action can be managed without interrupting the medication administration.

Choice A rationale

The cost of a medication is a logistical consideration, not a scientific or pharmacological basis for its clinical preference during labor. The selection of an analgesic is primarily determined by its therapeutic profile, including efficacy, safety for both mother and fetus, and its mechanism of action, rather than economic factors.

Choice B rationale

The administration route is a clinical characteristic, but it does not explain why these specific drugs are preferred. Butorphanol and nalbuphine are typically administered intravenously or intramuscularly, not orally, to achieve rapid onset and predictable plasma concentrations, which is crucial for managing acute labor pain.

Choice C rationale

These medications, like most opioids, are lipophilic and have low molecular weights, allowing them to readily cross the placental barrier via passive diffusion. This is a significant aspect of their pharmacology. The preference for these specific drugs lies in their partial agonist/antagonist activity, which mitigates some of the risks of fetal respiratory depression.

Choice D rationale

Butorphanol and nalbuphine are synthetic opioid agonist-antagonists. This unique pharmacological profile means they bind to and activate kappa opioid receptors while acting as antagonists or partial agonists at mu opioid receptors. This dual action provides effective pain relief while concurrently limiting the degree of respiratory depression compared to full mu-opioid agonists, making them a safer choice for both mother and fetus during labor. *.